Posts

August 07, 2014

+
11:01 PM | Has the biological revolution in rheumatoid arthritis peaked?
In the short term the focus looks set to be on personalised use of existing therapies
+
11:01 PM | emotive continues to grow
London digital agency appoints Aaron Joshua Barroso digital marketing manager
+
11:00 PM | Janssen looks to NASCAR for atrial fibrillation awareness
Company's MyAFibStory.com 400 kicks off the NASCAR Sprint Cup series
+
10:58 PM | The Worst Pain Known to Man… It’s a Stinger
A man stands ready, nervous but staunch. His face and hands are painted in warrior colors – black and red. Today, he will become a man. His initiation will be pain – pure, intense, brilliant pain. Walking over flaming charcoal with a nail in his heel pain. But his pain won’t come from fire, nor from a rusty nail. It won’t come from being attacked by a bull, a lion, or any other large, fierce creature. It won’t come from... Read more
+
8:12 PM | How Animation Is Changing Biology
Tweet This Post
+
8:02 PM | Chiropractic manipulation of neck may cause stroke
I usually don’t dwell too much on chiropractic, because so many other bloggers mock them so well. Chiropractors are generally antivaccination, they practice junk medicine in areas in which they are not trained, and they are essentially quacks utilizing some mystical alternative medicine, taking money from people who think they’re getting real medical treatment. Basically, chiropractic is […]Continue reading «Chiropractic manipulation of neck may cause […]
+
1:32 PM | What’s The Answer? (SNPs in promoters)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]
+
12:05 PM | Determining value to withstand all tests
The late arrival of an early role for communications
+
10:38 AM | Sanofi asks Emcure to sell its cancer drugs in India
Will hand over marketing of Taxotere, Jevtana, Fludara and Fasturtec
+
10:24 AM | India has big plans for healthcare and pharma
And the European industry is keen to engage with the new Modi government
+
10:12 AM | US talks tough on 'unpatriotic' tax inversion deals
Treasury looks to 'meaningfully reduce' tax benefits of such manoeuvres
+
9:48 AM | AbbVie begins 'first-of-its-kind' hep C charity pilot
Will work with Addaction Cornwall and The Hepatitis C Trust
+
8:50 AM | FDA approves antibacterial skin drug Orbactiv
US regulator authorises Medicines Company's treatment for ABSSSI
+
8:12 AM | Janssen launches online mental health video series
Healthy Minds will focus on brain disorder research and treatment

August 06, 2014

+
11:15 PM | Celgene's Abraxane authorised by Health Canada
Drug can now be used as first-line treatment for metastatic pancreatic cancer
+
7:47 PM | Fluorescent Cell Imaging Simplified
Tweet This Post
+
7:06 PM | ALS Target: Microglia
Glia, perhaps the most underappreciated of cell types, are finally getting some attention. A new report in Science Translational Medicine from Kevin Eggan’s group at the Harvard Stem Cell Institute validates the role of microglia in amyotrophic lateral sclerosis – aka ALS, motor neuron disease or Lou Gehrig’s disease — and investigates how to manipulate them to extend life, in a mouse model for now.… Read the restThe post ALS Target: Microglia appeared […]
+
1:36 PM | Video Tip of the Week: Biodalliance browser with HiSeq X-Ten data
Drama surrounding the $1000 genome erupts every so often, and earlier this year when the HiSeq X Ten setup was unveiled there was a lot of chatter–and questions: Is the $1,000 genome for real? And some push-back on the cost analysis: That “$1000 genome” is going to cost you $72M. A piece that offers nice […]

Down T.A. & T. J. P. Hubbard (2011). Dalliance: interactive genome viewing on the web, Bioinformatics, 27 (6) 889-890. DOI: http://dx.doi.org/10.1093/bioinformatics/btr020

Check Hayden E. (2014). Is the $1,000 genome for real?, Nature, DOI: http://dx.doi.org/10.1038/nature.2014.14530

Dunham I., Shelley F. Aldred, Patrick J. Collins, Carrie A. Davis, Francis Doyle, Charles B. Epstein, Seth Frietze, Jennifer Harrow, Rajinder Kaul & Jainab Khatun & (2012). An integrated encyclopedia of DNA elements in the human genome, Nature, 489 (7414) 57-74. DOI: http://dx.doi.org/10.1038/nature11247

Citation
+
10:47 AM | Actelion partners with PatientsLikeMe on blood cancer research
Will create patient-reported outcomes tool for rare form of non-Hodgkin’s lymphoma
+
10:14 AM | Roche's Avastin gets new EU nod in ovarian cancer
Wins new approval for hard-to-treat platinum-resistant recurrent form of disease
+
9:57 AM | FDA 'must publish biosimilar naming guide soon'
US politicians push regulator to finalise guidance
+
8:17 AM | Pfizer’s arthritis drug Enbrel widens its European licence
Gains new indication for early-stage inflammatory joint disease
+
7:55 AM | Sanofi and Regeneron pay $67.5m to speed alirocumab review
Buy FDA priority review voucher from BioMarin
+
7:48 AM | Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head
Moves to the Boston company from Onyx Pharmaceuticals

August 05, 2014

+
11:06 PM | Welcome to the new EpiBeat!
Wow! It’s been two years and we’ve come a long way! In commemoration of our two year anniversary, we have redesigned our website and have added multiple features to make things more fun, exciting, and most importantly, to keep you up to date on cutting-edge breakthroughs in epigenetic discovery!   ... The post Welcome to the new EpiBeat! appeared first on EpiBeat.
+
7:28 PM | Screening de portadores de Enfermedad de Gaucher en judíos Ashkenazi en Uruguay - update
En el marco del proyecto de Screening para judíos de origen Ashkenazí para la enfermedad de Gaucher, que venimos realizando en el laboratorio ya desde abril de este año, se está organizando una jornada de extracciones en conjunto con la Kehilá.La idea es hacer un evento intercomunitario, para así poder llegar a la mayor cantidad de gente posible y poder brindarle a todos quienes estén interesados la oportunidad de hacerlo.Por este motivo los […]
+
2:30 PM | Social Networking Key to Interspecies Infection
Fresh discoveries about how bacteria co-operate with each other when causing infection could help scientists identify animal diseases that might transmit to people. Bugs that can co-operate best with each other are most likely to be able to jump to new species, including humans, a new study shows. Bacteria interact by releasing molecules to help […]
+
2:03 PM | Brain cell transplant works in mice
The cool thing about stem cell technology is that it can work in adults. Whereas gene therapy, at least for now, only works in developing embryos. Scientists have turned fibroblasts from mouse skin into stem cells and injected them into the brains of adult mice. They then went back six months later and checked what […]
+
1:45 PM | Freedom to Focus: Maxwell® Rapid Sample Concentrator
Back in the dark ages, when I was a graduate student, my idea of “automated” plasmid DNA extraction involved performing home-brew, “toothpick preps” in “strip tubes” or , if I was really feeling ambitious, a 96-well plate. I would get just enough DNA to check for the presence of an insert, but the quality of […]
+
1:34 PM | Gene editing technique makes disease study almost as easy as flipping a switch
> Imagine you are about to interview someone, and rather than receiving a full reference letter, your candidate is described with but a single word. Do you think you’d get the whole picture? Of course you wouldn’t, but depending on the word chosen, you could make a decision. For example, “disorganized” or “unreliable” seem like...Read more
123456789
291 Results